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Circadian Expression Patterns of Proteins in the Suprachiasmatic Nucleus

Abstract
Previous studies indicate that several extracellular proteases are essential in the function of the central
nervous system. Plasmin is formed when plasminogen is cleaved by tissue plasminogen activator (tPA). In the
brain, plasmin catalyzes the formation of mature brain derived neurotrophic factor (mBDNF). Although it is
known that tPA protein is abundant in the hypothalamus, little attention has been given to its function there.
Based upon studies in the hippocampus, we hypothesized that tPA and its associated proteins modulate photic
phase resetting of the mammalian circadian clock in the suprachiasmatic nucleus (SCN) by activating BDNF.
We utilized an immortalized SCN2.2 cell line to examine tPA action within the SCN. This is an ideal model
because we hypothesize that tPA and its associated proteins function in the extracellular space, and cell culture
allows us to visualize and quantify proteins in the individual culture compartments—media, cells, and
extracellular matrix (ECM). Thus, we can examine protein interactions and functions both intracellularly and
extracellularly. We used Western Blot analysis of protein samples extracted from SCN2.2 cells to investigate
baseline expression patterns of these proteins. Cultures were synchronized to the same phase by forskolin
administration and then harvested and separated into fractions at three-hour intervals over a twenty-four hour
cycle. We analyzed cell fraction samples for the presence of tPA and plasminogen activator inhibitor 1 (PAI-1)
protein. Current data indicate that tPA is expressed rhythmically in the cell fraction, and that PAI-1 is not.
Since these proteins likely function extracellularly, their relative levels of expression in the media and ECM
fractions will provide important information regarding the functional interactions between these two proteins.
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Introduction
Within the mammalian hypothalamus, the suprachiasmatic nucleus (SCN) contains a circadian clock that
regulates the daily timing of many physiological and behavioral rhythms (Klein et al., 1991). These rhythms are
endogenously generated, and can be synchronized to environmental signals, called Zeitgebers, most notably
light signals received by the retina (Colwell et al., 1993).
Ganglion cells in the retina send light information to the
SCN through the retinohypothalamic tract (RHT). At the
SCN, RHT terminals release glutamate, which binds to
NMDA receptors on the postsynaptic SCN cells.

This

initiates a sharp increase in intracellular calcium, which
triggers a series of intracellular changes, ultimately resetting
the phase of the SCN clock. Studies have shown that brainderived neurotrophic factor (BDNF), a growth factor, must
concurrently activate its cognate TrkB receptors in order for
NMDA receptor activation to produce SCN clock phase
shifting (Prosser, 2001; Figure 1).
We hypothesize that a complex system of extracellular
proteins, traditionally associated with the fibrinolytic

Figure 1: This model illustrates the proposed
biochemical mechanism of light- and glutamateinduced phase shifting.

pathway and more recently shown to play a role in learning and memory in the hippocampus, also regulates
how the clock responds to glutamatergic signaling in the SCN. Tissue plasminogen activator (tPA) cleaves
plasminogen to form plasmin. Plasmin then cleaves proBDNF, the enzymatically inactive form of BDNF, to
develop mBDNF, the enzymatically active form of BDNF (Figure 2). This pathway is involved in the processes
that underlie learning and memory in the hippocampus (Pang et al., 2004). We are also interested in two
inhibitors that modulate the fibrinolytic pathway in the plasma. First, plasminogen activator inhibitor 1 (PAI-1),
stabilized by its cofactor vitronectin (VN; Podor et al., 2000), is the principle

inhibitor of tPA in the
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plasma (Neuhoff et al., 1999).

Second, α2-

antiplasmin inhibits plasmin activity (Collen and
Wiman, 1978). The roles of these inhibitors have
not been studied in the hippocampus.
Recent data in the Prosser lab indicate that tPA,
PAI-1, plasmin, plasminogen, and VN are all
expressed in the SCN. Further, these proteins and
their inhibitors are involved in the modulation of
photic phase shifts in SCN brain slices maintained
in vitro (Mou et al., 2009).

Furthermore, tPA,

mBDNF, and PAI-1 protein levels all exhibit 24
hour rhythms in SCN brain slices. Most relevant to
my research, his data show that tPA concentrations
are significantly higher during the night (Figure 3),

Figure 2: In the hippocampus, tissue plasminogen activator
(tPA) activates BDNF by converting plasminogen to
plasmin, which cleaves proBDNF to form mature BDNF
(mBDNF). mBDNF enhances glutamate-induced late
phase long term potentiation (L-LTP), which is involved in
memory formation. tPA is inhibited by plasminogen
activator inhibitor-1 (PAI-1), while vitronectin binds to and
enhances PAI-1 activity. The mechanisms that underlie LLTP and photic phase shifting are similar, and so we
hypothesize that this pathway is involved in BDNF
activation and, therefore, phase shifting in the SCN.

and that PAI-1 concentrations are significantly higher in the day (Figure 4; Mou et al, unpublished).

Figure 3: Data obtained from SCN brain slices.
Designation of day and night were based on the light
cycle in which the animal that provided the brain slice
was housed.
Source: X. Mou

Figure 4: Data obtained from SCN brain
slices. Dark bars indicate night and are
based on the light cycle in which the
mouse was housed.
Source: X. Mou

While these data on SCN clock phase resetting and protein expression rhythms give an indication of how
these proteins function in the SCN, they do not provide the whole story. These proteins are secreted and
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generally act extracellularly, sometimes bound to the extracellular matrix or cell surface proteins. The proteins
they interact with largely determine their activity. Thus, protein expression in whole tissue samples only begins
to describe their potential function in the SCN.
My project was to determine the temporal patterns of expression, and cellular localization, of tPA and PAI-1
in SCN2.2 cells working with post-doctoral fellow, Dr. Elizabeth Cantwell.

The SCN2.2 cell line, an

immortalized heterogeneous cell culture derived from fetal rat SCN (Earnest et al., 1999b), serves as an
appropriate model for the rat SCN circadian clock due to several of its special characteristics. First, all proteins
and mRNAs studied and published on in this cell line are expressed in the same manner as they are in the rat
SCN (Earnest et al., 1999a, 1999b; Allen et al., 2001; Allen and Earnest, 2002; Hurst et al., 2002a, 2002b).
Second, these cells can sustain endogenous circadian rhythms in culture (Earnest et al., 1999b) and can restore
behavioral rhythmicity if they are implanted into an SCN-lesioned animal (Earnest et al., 1999a). Finally,
SCN2.2 cells can synchronize rhythms of metabolic activity and gene expression in arrhythmic cells when kept
in co-culture conditions (Allen et al., 2001). Using the SCN2.2 cell line allows us to refine our understanding of
how these proteins function in the SCN by allowing us to differentiate their location between the culture media,
which represents extracellular fluid, the cellular fraction, and the extracellular matrix (ECM). We hypothesize
that at least some of the proteins are expressed at higher levels during the night than in the day, similar to the
SCN brain slices also studied in our lab. However, there is little upon which to base speculation regarding the
distribution of these proteins among the different compartments over the 24-hour cycle. Up until this point,
most studies investigating photic phase shifting have focused on intercellular processes, so this is a novel line of
research.

Methods
SCN2.2 Cell Cultures
My experiments utilize a heterogeneous immortalized cell line derived from the embryonic rat SCN called
SCN2.2 cells. We obtained the cell line from Dr. David J. Earnest of Texas A&M University and developed our
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own stock, which is frozen in cryotubes and kept in liquid nitrogen. We maintain the cultures according to his
established protocols (Earnest et al., 1999a and personal communications).
To start a culture, cryotube stock is incubated in a water bath at 37°C for one to two minutes. Thawed stock
is then pipetted into a fifteen milliliter Falcon tube already containing eight milliliters of warm growth media
(Minimal Essential Media containing 20% fetal bovine serum (FBS), 0.4% glucose, 1% L-glutamine, 50 µg/mL
gentamicin). The cryotube is rinsed with an additional one milliliter of media to remove any cells that remain,
and this is transferred to the Falcon tube making the total volume ten milliliters. The Falcon tube is centrifuged
(900 rpm, room temperature) for five minutes. The supernatant is then removed and the pellet is resuspended
with a glass pipette in one milliliter of media. The resuspended cells are then transferred to a sixty millimeter
Petri dish coated with laminin to encourage adherence. Three milliliters of warm medium is added to the dish,
and it is incubated in a standard culture incubator (5% carbon dioxide, 37°C). The media is changed every
twenty-four hours.
Under these conditions, the cells divide at a rapid rate. When the cells reach 100% confluence, meaning they
cover the surface of the dish, we passage the cells. In the first passage, cells from the Petri dish are distributed,
or seeded, into a flask that has roughly three times the area. In further passages, cells from one flask are seeded
into three flasks. In this way, we are able to produce multiple flasks for experimentation from one cryotube of
stock. To begin a passage, the confluent dish is rinsed with sterile Calcium-Magnesium Free buffer (CMF;
phosphate buffered saline containing 0.2% glucose and 50 µg/mL gentamicin). Two milliliters of 0.05%
Trypsin/EDTA is added to the dish, and it is incubated for one minute at 37°C, which causes the cells to lift
from the surface of the dish. As they lift, the cells take on a spherical appearance. At this point, we add 0.2
milliliters of FBS and mix gently to stop the trypsinization. The cells are then triturated gently with a glass
pipette until at least ninety-five percent of the cells are detached. The cells suspended in Trypsin/FBS are
transferred to a fifteen milliliter Falcon tube and centrifuged (900 rpm; room temperature) for five minutes. The
supernatant is discarded, and the cell pellet is resuspended in 1 mL of fresh growth media with a glass pipette.
After adjusting the volume appropriately, 1 mL of resuspended cells in media is put into each flask, and
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additional growth media is added to bring the flask volume to 10 mL. The dishes are incubated at 37°C, and the
media is changed every 24 to 48 hours, depending on the rate of growth.

Synchronization
At the point where we have passaged nine dishes and they have reached about 75% confluence, we being
our synchronization protocol. Media is removed and replaced with growth media containing 5% FBS eight
hours before synchronization. The dishes are then rinsed with CMF, and we add B-27 media (Neurobasal media
containing 0.81% glucose, 1% L-glutamine, 50µg/mL gentamicin, and 2% B-27 nutritional supplement)
containing 15 µM forskolin in 0.01% DMSO (old protocol) or 0.1% DMSO (new protocol). After incubating
for two hours at 37°C, the flasks are rinsed with CMF and filled with 10 mL fresh B-27 media, except the flask
to be harvested at the first timepoint, which is filled with 5 mL of fresh B-27 media.

Harvesting
Three hours after synchronization ends, the timecourse of sample collection begins. Cultures are harvested
at three-hour intervals over a twenty-four hour cycle, one flask at each timepoint. At the outset of each
timepoint, the media in the flask to be harvested 3 hours later is replaced with five milliliters of fresh B-27.
Then, sample collection begins
(Figure 5). First, media is collected,
cleared,
Eppendorf

and

aliquotted

tubes.

Second,

into
the

remaining culture is rinsed, and
0.02M ammonium hydroxide is
applied to the remaining culture for
ten minutes at room temperature to

Figure 5: This harvesting protocol allows us to collect three fractions from
each SCN2.2 culture.

solubilize the cells remaining the
flask. The cell fraction is collected, mixed, and aliquotted into Eppendorf tubes. Third, the remaining
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extracellular matrix (ECM) is rinsed and solubilized in 1M sodium hydroxide. After manual agitation, pH is
equilibrated with 1M acetic acid, and the ECM fraction is collected, mixed, and aliquotted into Eppendorf tubes.
The three sample fractions are stored at -80°C until they are thawed for protein extraction.

Protein Extraction
My experiments have utilized the cell fraction of the SCN2.2 cell line. Proteins are precipitated in 10%
trichloroacetic acid (TCA). To accomplish this concentration, a ten percent volume of ice-cold 100% TCA in
acetone is added to 50 µL of each cell fraction collected over the timecourse. This solution is incubated for ten
minutes on ice, and then centrifuged (17g, 4°C) for 30 minutes. The supernatant is discarded, and the protein
pellet is rinsed with 250 µL of ice- cold 1% TCA in acetone for 10 minutes on ice. The rinsed pellet is thencentrifuged, as before, for 15 minutes. The 1% TCA rinse is repeated once. Next, the pellet is rinsed with 250
µL of ice-cold acetone three times in the same manner as the 1% TCA rinses. Finally, the protein pellets are left
overnight at room temperature to dry.

Western Blotting Procedure
Protein in the dried pellets is reconstituted in loading buffer (80mM Tris, 2% SDS, 100mM Dithiothrietal,
10% glycerol, 0.01% bromophenol blue). A uniform volume of each sample is loaded into separate wells of an
acrylamide gel (4% stacking, 10% resolving), as is a ladder, consisting of proteins of known molecular weight
covalently bonded to visible dyes, and a purified protein control, appropriate to the protein I am going to
visualize. Proteins in the samples are separated by molecular weight using gel electrophoresis. Because these
proteins are negatively charged, and the current applied creates a negative pole at the top and a positive pole at
the bottom, the proteins migrate through the pores of the acrylamide gel such that the larger proteins migrate
slowly and stay close to the wells, and the smaller proteins move through the gel quickly and end up further
from the wells. Proteins are transferred from the gel to a nitrocellulose membrane in an apparatus that also
applies current, allowing them to migrate from the gel to the membrane, where they are crosslinked. Once
proteins have been transferred, the membrane is subjected to standard Western blot techniques utilizing primary
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antibodies generated against tPA and PAI-1. Secondary antibodies conjugated with horseradish peroxidase
(HRP) allow me to visualize my protein by applying a chemiluminescent substrate, which, when cleaved by the
HRP, emits visible light. By exposing photographic film to the membrane and then developing it, we get a
permanent image of protein expression in the cell fraction of the SCN2.2 cell line. The same membranes are
then probed using primary antibodies generated against actin, and these values are used to normalize protein
data as discussed below.

Data Analysis
To analyze my data, I digitize films on a scanner and use the ImageJ program (NIH, Bethesda, MD) to
quantify the density of bands representing protein expression. The data for each sample are normalized by
expressing the values for the protein of interest and actin from each sample as a ratio. The data are stored on an
Excel spreadsheet, and graphs are made from the data. Statistical analysis is performed on the JMP 8 statistical
discovery software by SAS (Cary, NC). Significance is determined using a one-way analysis of variance
(ANOVA), followed by Student’s T post-hoc test.

Results
tPA Expression in the SCN
Preliminary data were obtained from the cell fraction of the
SCN2.2 cell line following the old synchronization protocol
(Figure 6). Data from two Western blots support findings in the
SCN brain slice; however, since statistical analysis is not
appropriate in this case (with only 2 replicates), we cannot
determine significance.
Data obtained under the new synchronization protocol
indicates that there is a significant difference in tPA expression

Figure 6: Preliminary data obtained prior to
refinement of our synchronization protocol.
Designation of day and night were based on
forskolin synchronization in previous studies.
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across time (p<0.05), in the cell fraction of the SCN2.2
cell line, Post-hoc analysis indicates that tPA expression
at ZT21 (late night) is significantly higher than
expression at ZT18 (mid-night; p=0.016) and ZT 6 (midday; p=0.042). However, we found no statistically
significant difference in overall tPA expression from day
to night (Figure 7).

Figure 7: Data obtained from the cell fraction of the
SCN2.2 cell line following the new synchronization
protocol. Designation of Zeitgeber time and day
versus night (dark bars) are based on forskolin
synchronization in other studies. Letters denote
groups based upon statistical analysis. A, AB, and B
indicate statistically different data.

Figure 8: Preliminary data obtained prior to
refinement of our synchronization protocol. Black
bars indicate night, designation based on previous
studies.

PAI-1 Expression in the SCN
Preliminary data from the cell fraction of the
SCN2.2

cell

line

obtained

following

the

old

synchronization protocol indicate that there is no
significant difference in PAI-1 expression over the
course of the 24-hour cycle (Figure 8).
Data obtained from the cell fraction following the
new synchronization protocol are inconclusive at this

Figure 9: Data obtained from the cell fraction of the
SCN2.2 cell line following the new synchronization
protocol. Black bars indicate night, designation based
on previous studies.
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time. This data show a high peak in PAI-1 expression during the late night (Figure 9). Because only one
replication was successful, statistical analysis is not appropriate.

Discussion
In this study, we have shown that, in the cell fraction of the SCN2.2 cell line, tPA protein expression varies
significantly over the course of the day. PAI-1 expression, while not subjected to statistics, seems to peak in the
late night. There are several aspects of these data that are quite important.
The data obtained from Xiang Mou indicates that tPA expression is significantly higher in the night (Figure
3), while PAI-1 levels are significantly higher during the day (Figure 4) in SCN brain slices. However, these
data leave open questions as to where and when tPA and PAI-1 are expressed in the SCN. We chose to address
this issue using the SCN2.2 culture system because we can research the localization of these proteins over the
twenty-four hour cycle.
The SCN brain slice data (Figure 3) demonstrated that tPA is significantly higher in the night than in the day
in SCN brain slices. However, according to our cell culture data (Figure 7), there is no statistically significant
difference between tPA expression in the day versus the night. However, the data show a significant peak
(Figure 7, peak A) toward the end of the night. When comparing these data with those from whole SCN tissue,
this could mean that tPA is localized to the media or extracellular matrix strongly during the night.
While the SCN brain slice data and preliminary data reveal higher expression of tPA at night than in the
day, our more recent cell culture data (Figure 7) did not support this pattern in the cell fraction. One reason for
this discrepancy could be the procedural changes in the cell culture technique. We increased the volume of
DMSO, a substance used to dissolve forskolin, which is hydrophobic. This was necessary because we
discovered that the volume being used before was not dissolving all of the forskolin. If the forskolin does not
dissolve completely, the cells will not synchronize. However, DMSO is toxic to the cells, so this could have
affected the growth of the cells over the 24-hour time course, therefore affecting cells in the different flasks
differently. While visual inspection of the cells indicated that they were healthy following the forskolin pulse,
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there is a possibility that they were dying over time. Thus, we may have to reassess the synchronization process
because as cells die, they may release tPA into the media, and this would skew the tPA expression data obtained
from the media fraction. Therefore, tPA expression data from the media fraction should be highly informative
as to this issue.
The fact that forskolin dissolves completely remains so important because we assume that forskolin
synchronizes our cells as it did in other studies because the best indicator of what phase the cells are in is
BDNF. In previous studies, BDNF expression was assessed by an ELISA kit; however, that kit was
discontinued by the manufacturer. Adjusting our western blot procedure to quantify BDNF has been a
challenge.
While PAI-1 expression in the SCN2.2 cell fractions has shown no rhythmicity, it might be rhythmic in one
or both of the other two fractions. My data suggests that PAI-1 may be expressed in higher levels at night, but
this does not fit with the SCN brain slice data. However, since PAI-1 is only active when bound to the
extracellular matrix, we might find high PAI-1 levels a few hours later in the ECM and media where it is
actually active. This would make sense, given that inhibition of tPA during the day would halt activation of
BDNF, and it is during the day that the SCN cannot phase shift in response to light or glutamate.
Obviously, we need to continue our investigation of all three compartments with each protein to
determine what is being expressed where. However, presence of these proteins is not the only issue: we also
need to determine when tPA and PAI-1 are enzymatically active.
From a real-world standpoint, this research is extremely significant. If we understand how light phase shifts
the clock, we may be able to find a way to make jet lag obsolete by modulating the proteins that play the most
important roles in photic clock synchronization. Also, links have been found between BDNF expression and
post-traumatic stress disorder (PTSD; Bremner 2006). If we can manipulate BDNF expression, that could help
us develop a potential treatment for PTSD. Further, incorrect synchronization of the SCN has been linked to a
wide variety of psychiatric disorders such as schizophrenia, depression, seasonal affective disorder. New
treatments could be developed with a greater understanding of how the circadian system works.
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Conclusion
The preliminary data showed higher tPA expression in the SCN2.2 cells at night, but more recent data
did not confirm this. Preliminary data also indicated no rhythm in PAI-1 expression in the SCN2.2 cells. The
Western blot completed under the new synchronization protocol suggests higher levels at night, but it is based
on only one replication. This research will be continued by further experimentation focusing on protein levels in
the media and ECM fractions.
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